{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:00:42Z","timestamp":1780059642601,"version":"3.54.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004351"],"award-info":[{"award-number":["82004351"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021ZYD0107"],"award-info":[{"award-number":["2021ZYD0107"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["QJRC2022008"],"award-info":[{"award-number":["QJRC2022008"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Jin-Gui-Shen-Qi Wan (JGSQ) has been used in China for thousands of years to treat various ailments, including frequent urination, blurred vision, and soreness in the waist and knees. It has traditional therapeutic advantages in improving eye diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim of the study<\/jats:title>\n                <jats:p>Clinical studies have confirmed the therapeutic efficacy of JGSQ in improving diabetes and vision; however, its efficacy and pharmacological effects in treating diabetic retinopathy (DR) remain unclear. Therefore, the aim of this study was to investigate the specific pharmacological effects and potential mechanisms of JGSQ in improving DR through a <jats:italic>db\/db<\/jats:italic> model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p><jats:italic>db\/db<\/jats:italic> mice were given three different doses of orally administered JGSQ and metformin for 8\u00a0weeks, and then PAS staining of the retinal vascular network patch, transmission electron microscopy, H&amp;E staining, and TUNEL staining were performed to determine the potential role of JGSQ in improving DR-induced neuronal cell apoptosis. Furthermore, network pharmacology analysis and molecular docking were carried out to identify the main potential targets of JGSQ, and the efficacy of JGSQ in improving DR was evaluated through western blotting and immunofluorescence staining, revealing its mechanism of action.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>According to the results from H&amp;E, TUNEL, and PAS staining of the retinal vascular network patch and transmission electron microscopy, JGSQ does not have an advantage in improving the abnormal morphology of vascular endothelial cells, but it has a significant effect on protecting retinal ganglion cells from apoptosis. Through network pharmacology and molecular docking, AKT, GAPDH, TNF, TP53, and IL-6 were identified as the main core targets of JGSQ. Subsequently, through western blot and immunofluorescence staining, it was found that JGSQ can inhibit HIF-1\u03b1, promote p-AKT expression, and inhibit TP53 expression. At the same time, inhibiting the release of inflammatory factors protects retinal ganglion cells and improves apoptosis in DR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results indicated that in the <jats:italic>db\/db<\/jats:italic> DR mouse model, JGSQ can inhibit the expression of inflammatory cytokines and protect retinal ganglion cells from apoptosis, possibly by modulating the Akt\/HIF-1\u03b1 pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13020-023-00840-7","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:02:22Z","timestamp":1697104942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt\/HIF-1\u03b1 pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Dan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-6772","authenticated-orcid":false,"given":"Nianzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"840_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. The Lancet. 2010;376:124\u201336.","journal-title":"The Lancet"},{"key":"840_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"840_CR3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaophthalmol.2022.3470","volume":"140","author":"S Zhou","year":"2022","unstructured":"Zhou S, Shen C. Statistical considerations for meta-analysis of diabetic retinopathy prevalence. JAMA Ophthalmol. 2022;140:1141.","journal-title":"JAMA Ophthalmol"},{"key":"840_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055087","author":"T Yue","year":"2022","unstructured":"Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X. The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.1055087.","journal-title":"Front Immunol"},{"key":"840_CR5","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.2165\/11538130-000000000-00000","volume":"70","author":"F Boscia","year":"2010","unstructured":"Boscia F. Current approaches to the management of diabetic retinopathy and diabetic macular oedema. Drugs. 2010;70:2171\u2013200.","journal-title":"Drugs"},{"key":"840_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17:195\u2013206.","journal-title":"Nat Rev Endocrinol"},{"key":"840_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","volume":"51","author":"AW Stitt","year":"2016","unstructured":"Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156\u201386.","journal-title":"Prog Retin Eye Res"},{"key":"840_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s11427-015-4858-8","volume":"58","author":"T Zhu","year":"2015","unstructured":"Zhu T, Ma J, Li Y, Zhang Z. Association between retinal neuronal degeneration and visual function impairment in type 2 diabetic patients without diabetic retinopathy. Sci China Life Sci. 2015;58:550\u20135.","journal-title":"Sci China Life Sci"},{"key":"840_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106516","volume":"185","author":"R Amato","year":"2022","unstructured":"Amato R, Catalani E, Dal Monte M, Cammalleri M, Cervia D, Casini G. Morpho-functional analysis of the early changes induced in retinal ganglion cells by the onset of diabetic retinopathy: the effects of a neuroprotective strategy. Pharmacol Res. 2022;185: 106516.","journal-title":"Pharmacol Res"},{"key":"840_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12716","author":"R Huang","year":"2021","unstructured":"Huang R, Xu Y, Lu X, Tang X, Lin J, Cui K, et al. Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. J Pineal Res. 2021. https:\/\/doi.org\/10.1111\/jpi.12716.","journal-title":"J Pineal Res"},{"key":"840_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12473","volume":"64","author":"Y Xu","year":"2018","unstructured":"Xu Y, Lu X, Hu Y, Yang B, Tsui C-K, Yu S, et al. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1\u03b1-VEGF pathway in oxygen-induced retinopathy mice. J Pineal Res. 2018;64: e12473.","journal-title":"J Pineal Res"},{"key":"840_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4103\/1673-5374.355743","volume":"18","author":"L Tang","year":"2023","unstructured":"Tang L, Xu G-T, Zhang J-F. Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. Neural Regen Res. 2023;18:976.","journal-title":"Neural Regen Res"},{"key":"840_CR13","volume-title":"Synopsis of the golden chamber","author":"Z Zhang","year":"2016","unstructured":"Zhang Z. Synopsis of the golden chamber. Beijing: New world press; 2016."},{"key":"840_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jep.2018.08.028","volume":"227","author":"S-T Kao","year":"2018","unstructured":"Kao S-T, Wang S-D, Lin C-C, Lin L-J. Jin Gui Shen Qi Wan, a traditional Chinese medicine, alleviated allergic airway hypersensitivity and inflammatory cell infiltration in a chronic asthma mouse model. J Ethnopharmacol. 2018;227:181\u201390.","journal-title":"J Ethnopharmacol"},{"key":"840_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.699932","author":"Z Hu","year":"2021","unstructured":"Hu Z, Liu X, Yang M. Evidence and potential mechanisms of Jin-Gui Shen-Qi Wan as a treatment for type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.699932.","journal-title":"Front Pharmacol"},{"key":"840_CR16","unstructured":"Cai H, Liu F. 2014. 43 cases of diabetic retinopathy treated with traditional Chinese medicine based on syndrome differentiation. Henan Tradit Chinese medicine. 2014; 1786\u20137."},{"key":"840_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114443","volume":"280","author":"W Chen","year":"2021","unstructured":"Chen W, Wang B, Ding C, Wan L, Hu H, Lv B, et al. In vivo and in vitro protective effects of the Wuzi Yanzong pill against experimental spermatogenesis disorder by promoting germ cell proliferation and suppressing apoptosis. J Ethnopharmacol. 2021;280: 114443.","journal-title":"J Ethnopharmacol"},{"key":"840_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1423-0127-20-38","volume":"20","author":"DH Jo","year":"2013","unstructured":"Jo DH, Cho CS, Kim JH, Jun HO, Kim JH. Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics. J Biomed Sci. 2013;20:38.","journal-title":"J Biomed Sci"},{"key":"840_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8:92.","journal-title":"Signal Transduct Target Ther"},{"key":"840_CR20","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1038\/cddis.2012.138","volume":"3","author":"G Nayak","year":"2012","unstructured":"Nayak G, Cooper GM. p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase\/Akt\/GSK3 signaling. Cell Death Dis. 2012;3:e400\u2013e400.","journal-title":"Cell Death Dis"},{"key":"840_CR21","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.7150\/ijbs.62868","volume":"17","author":"N Wang","year":"2021","unstructured":"Wang N, Zhang C, Xu Y, Tan H-Y, Chen H, Feng Y. Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt\/mTOR-mediated HIF-1\u03b1\/VEGF activation in retina endothelial cells. Int J Biol Sci. 2021;17:4316\u201326.","journal-title":"Int J Biol Sci"},{"key":"840_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13046-018-0730-6","volume":"37","author":"Y-H Yeh","year":"2018","unstructured":"Yeh Y-H, Hsiao H-F, Yeh Y-C, Chen T-W, Li T-K. Inflammatory interferon activates HIF-1\u03b1-mediated epithelial-to-mesenchymal transition via PI3K\/AKT\/mTOR pathway. J Exp Clin Cancer Res. 2018;37:70.","journal-title":"J Exp Clin Cancer Res"},{"key":"840_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1077669","author":"T-E Tan","year":"2023","unstructured":"Tan T-E, Wong TY. Diabetic retinopathy: looking forward to 2030. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2022.1077669.","journal-title":"Front Endocrinol"},{"key":"840_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942768","author":"K Lv","year":"2022","unstructured":"Lv K, Ying H, Hu G, Hu J, Jian Q, Zhang F. Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.942768.","journal-title":"Front Immunol"},{"key":"840_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160\u201380.","journal-title":"Prog Retin Eye Res"},{"key":"840_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14084","author":"H Ma","year":"2022","unstructured":"Ma H, Li J. The ginger extract could improve diabetic retinopathy by inhibiting the expression of e\/iNOS and G6PDH, apoptosis, inflammation, and angiogenesis. J Food Biochem. 2022. https:\/\/doi.org\/10.1111\/jfbc.14084.","journal-title":"J Food Biochem"},{"key":"840_CR27","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.16334","volume":"12","author":"J Wu","year":"2016","unstructured":"Wu J, Ke X, Wang W, Zhang H, Ma N, Fu W, et al. Aloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1\u03b1\/VEGF pathway. Int J Biol Sci. 2016;12:1363\u201371.","journal-title":"Int J Biol Sci"},{"key":"840_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1610751","volume":"2018","author":"W Du","year":"2018","unstructured":"Du W, An Y, He X, Zhang D, He W. Protection of kaempferol on oxidative stress-induced retinal pigment epithelial cell damage. Oxid Med Cell Longev. 2018;2018:1\u201314.","journal-title":"Oxid Med Cell Longev"},{"key":"840_CR29","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.3390\/ijms18112497","volume":"18","author":"M Lee","year":"2017","unstructured":"Lee M, Yun S, Lee H, Yang J. Quercetin mitigates inflammatory responses induced by vascular endothelial growth factor in mouse retinal photoreceptor cells through suppression of nuclear factor kappa B. Int J Mol Sci. 2017;18:2497.","journal-title":"Int J Mol Sci"},{"key":"840_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110573","volume":"130","author":"S Wang","year":"2020","unstructured":"Wang S, Du S, Wang W, Zhang F. Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy. Biomed Pharmacother. 2020;130: 110573.","journal-title":"Biomed Pharmacother"},{"key":"840_CR31","first-page":"1","volume":"2021","author":"Y Tu","year":"2021","unstructured":"Tu Y, Li L, Zhu L, Guo Y, Du S, Zhang Y, et al. Geniposide attenuates hyperglycemia-induced oxidative stress and inflammation by activating the Nrf2 signaling pathway in experimental diabetic retinopathy. Oxid Med Cell Longev. 2021;2021:1\u201315.","journal-title":"Oxid Med Cell Longev"},{"key":"840_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.vph.2018.04.005","volume":"108","author":"S Shanmuganathan","year":"2018","unstructured":"Shanmuganathan S, Angayarkanni N. Chebulagic acid chebulinic acid and gallic acid, the active principles of Triphala, inhibit TNF\u03b1 induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38 ERK and NFkB phosphorylation. Vascul Pharmacol. 2018;108:23\u201335.","journal-title":"Vascul Pharmacol"},{"key":"840_CR33","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10753-017-0571-z","volume":"40","author":"S-H Zhu","year":"2017","unstructured":"Zhu S-H, Liu B-Q, Hao M-J, Fan Y-X, Qian C, Teng P, et al. Paeoniflorin suppressed high glucose-induced retinal microglia MMP-9 expression and inflammatory response via inhibition of TLR4\/NF-\u03baB pathway through upregulation of SOCS3 in diabetic retinopathy. Inflammation. 2017;40:1475\u201386.","journal-title":"Inflammation"},{"key":"840_CR34","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.2147\/DDDT.S114022","volume":"10","author":"J Wu","year":"2016","unstructured":"Wu J, Ke X, Ma N, Wang W, Fu W, Zhang H, et al. Formononetin, an active compound of <em>Astragalus membranaceus<\/em> (Fisch) Bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1&alpha;\/VEGF signaling pathway. Drug Des Devel Ther. 2016;10:3071\u201381.","journal-title":"Drug Des Devel Ther"},{"key":"840_CR35","first-page":"1","volume":"2021","author":"L Pan","year":"2021","unstructured":"Pan L, Cho K-S, Yi I, To C-H, Chen DF, Do C-W. Baicalein, baicalin, and wogonin: protective effects against ischemia-induced neurodegeneration in the brain and retina. Oxid Med Cell Longev. 2021;2021:1\u201316.","journal-title":"Oxid Med Cell Longev"},{"key":"840_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119567","volume":"277","author":"M Fang","year":"2021","unstructured":"Fang M, Wan W, Li Q, Wan W, Long Y, Liu H, et al. Asiatic acid attenuates diabetic retinopathy through TLR4\/MyD88\/NF-\u03baB p65 mediated modulation of microglia polarization. Life Sci. 2021;277: 119567.","journal-title":"Life Sci"},{"key":"840_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.564077","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia UM, Wolf A, Langmann T. Microglia and inflammatory responses in diabetic retinopathy. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.564077.","journal-title":"Front Immunol"},{"key":"840_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, et al. Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17:590\u2013603.","journal-title":"Leukemia"},{"key":"840_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154276","volume":"104","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wu Q, Wang H, Gao Y, Nie K, Tang Y, et al. Diosgenin protects against podocyte injury in early phase of diabetic nephropathy through regulating SIRT6. Phytomedicine. 2022;104: 154276.","journal-title":"Phytomedicine"},{"key":"840_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154661","volume":"111","author":"K Nie","year":"2023","unstructured":"Nie K, Gao Y, Chen S, Wang Z, Wang H, Tang Y, et al. Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake. Phytomedicine. 2023;111: 154661.","journal-title":"Phytomedicine"},{"key":"840_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000507398","volume":"80","author":"N Mahmoudi","year":"2021","unstructured":"Mahmoudi N, Kiasalari Z, Rahmani T, Sanaierad A, Afshin-Majd S, Naderi G, et al. Diosgenin attenuates cognitive impairment in streptozotocin-induced diabetic rats: underlying mechanisms. Neuropsychobiology. 2021;80:25\u201335.","journal-title":"Neuropsychobiology"},{"key":"840_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.698","author":"Y Hao","year":"2022","unstructured":"Hao Y, Gao X. Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating AMPK\/Nrf2\/HO-1 pathway. Immun Inflamm Dis. 2022. https:\/\/doi.org\/10.1002\/iid3.698.","journal-title":"Immun Inflamm Dis"},{"key":"840_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.21873\/invivo.13126","volume":"37","author":"WL Liao","year":"2023","unstructured":"Liao WL, Huang CP, Wang HP, Lei YJ, Lin HJ, Huang YC. Diosgenin, a natural steroidal sapogenin, alleviates the progression of diabetic retinopathy in diabetic mice. In Vivo. 2023;37:661\u20136.","journal-title":"In Vivo"},{"key":"840_CR44","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3390\/ijms24021024","volume":"24","author":"K Gomu\u0142ka","year":"2023","unstructured":"Gomu\u0142ka K, Ruta M. The role of inflammation and therapeutic concepts in diabetic retinopathy\u2014a short review. Int J Mol Sci. 2023;24:1024.","journal-title":"Int J Mol Sci"},{"key":"840_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s11658-018-0100-6","volume":"23","author":"M Fei","year":"2018","unstructured":"Fei M, Guan J, Xue T, Qin L, Tang C, Cui G, et al. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1\u03b1\u2013IL-8\u2013Akt axis. Cell Mol Biol Lett. 2018;23:46.","journal-title":"Cell Mol Biol Lett"},{"key":"840_CR46","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1038\/onc.2011.174","volume":"30","author":"J-H Park","year":"2011","unstructured":"Park J-H, Lee J-Y, Shin D-H, Jang K-S, Kim H-J, Kong G. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1\u03b1 mediated by the PTEN\/PI3K\/Akt pathway. Oncogene. 2011;30:4578\u201389.","journal-title":"Oncogene"},{"key":"840_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13287-019-1168-2","volume":"10","author":"C Yang","year":"2019","unstructured":"Yang C, Liu X, Zhao K, Zhu Y, Hu B, Zhou Y, et al. miRNA-21 promotes osteogenesis via the PTEN\/PI3K\/Akt\/HIF-1\u03b1 pathway and enhances bone regeneration in critical size defects. Stem Cell Res Ther. 2019;10:65.","journal-title":"Stem Cell Res Ther"},{"key":"840_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01667","author":"G Wu","year":"2018","unstructured":"Wu G, Xu G, Chen D-W, Gao W-X, Xiong J-Q, Shen H-Y, et al. Hypoxia exacerbates inflammatory acute lung injury via the toll-like receptor 4 signaling pathway. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01667.","journal-title":"Front Immunol"},{"key":"840_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cmi.2015.78","volume":"14","author":"G Huang","year":"2017","unstructured":"Huang G, Su J, Zhang M, Jin Y, Wang Y, Zhou P, et al. RhoB regulates the function of macrophages in the hypoxia-induced inflammatory response. Cell Mol Immunol. 2017;14:265\u201375.","journal-title":"Cell Mol Immunol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-023-00840-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:37:54Z","timestamp":1700408274000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-023-00840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1186\/s13020-023-00840-7","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by Institutional Animal Care and Use Committee of Hospital of Chengdu University of Traditional Chinese Medicine (Approval number: 2023KL-010), accordance with the internationally accepted principles for laboratory animal use and care as found the European Community guidelines (EEC Directive of 1986; 86\/609\/EEC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed with the content of the manuscript and approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}